Marshall Wace’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-57,908
| Closed | -$906K | – | 2528 |
|
|
2025
Q1 | $906K | Buy |
+57,908
| New | +$906K | ﹤0.01% | 1723 |
|
|
2024
Q1 | – | Sell |
-95,011
| Closed | -$307K | – | 2106 |
|
|
2023
Q4 | $307K | Sell |
95,011
-2,216,066
| -96% | -$7.16M | ﹤0.01% | 1581 |
|
|
2023
Q3 | $12.3M | Sell |
2,311,077
-6,464
| -0.3% | -$34.3K | 0.02% | 531 |
|
|
2023
Q2 | $22.1M | Buy |
2,317,541
+12,205
| +0.5% | +$116K | 0.04% | 393 |
|
|
2023
Q1 | $25.4M | Buy |
+2,305,336
| New | +$25.4M | 0.05% | 325 |
|
|
2022
Q4 | – | Sell |
-167,816
| Closed | -$3.21M | – | 2309 |
|
|
2022
Q3 | $3.21M | Buy |
+167,816
| New | +$3.21M | 0.01% | 1370 |
|
|
2021
Q3 | – | Sell |
-15,138
| Closed | -$413K | – | 2379 |
|
|
2021
Q2 | $413K | Sell |
15,138
-154,349
| -91% | -$4.21M | ﹤0.01% | 1738 |
|
|
2021
Q1 | $4.9M | Buy |
169,487
+90,514
| +115% | +$2.62M | 0.02% | 772 |
|
|
2020
Q4 | $2.22M | Buy |
+78,973
| New | +$2.22M | 0.01% | 826 |
|